{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,22]],"date-time":"2026-10-22T21:47:31Z","timestamp":1792705651263,"version":"4.5.0"},"reference-count":19,"publisher":"American Association for Cancer Research (AACR)","issue":"24","content-domain":{"domain":["aacrjournals.org"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2006,12,15]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>Tumor necrosis factor-\u03b1 (TNF-\u03b1) is an important inflammation cytokine without known direct effect on DNA. In this study, we found that TNF-\u03b1 can cause DNA damages through reactive oxygen species. The mutagenic effect of TNF-\u03b1 is comparable with that of ionizing radiation. TNF-\u03b1 treatment in cultured cells resulted in increased gene mutations, gene amplification, micronuclei formation, and chromosomal instability. Antioxidants significantly reduced TNF-\u03b1\u2013induced genetic damage. TNF-\u03b1 also induced oxidative stress and nucleotide damages in mouse tissues in vivo. Moreover, TNF-\u03b1 treatment alone led to increased malignant transformation of mouse embryo fibroblasts, which could be partially suppressed by antioxidants. As TNF-\u03b1 is involved in chronic inflammatory diseases, such as chronic hepatitis, ulcerative colitis, and chronic skin ulcers, and these diseases predispose the patients to cancer development, our results suggest a novel pathway through which TNF-\u03b1 promotes cancer development through induction of gene mutations, in addition to the previously reported mechanisms, in which nuclear factor-\u03baB activation was implicated. (Cancer Res 2006; 66(24): 11565-70)<\/jats:p>","DOI":"10.1158\/0008-5472.can-06-2540","type":"journal-article","created":{"date-parts":[[2006,12,18]],"date-time":"2006-12-18T12:57:56Z","timestamp":1166446676000},"page":"11565-11570","update-policy":"https:\/\/doi.org\/10.1158\/crossmark_policy","source":"Crossref","is-referenced-by-count":148,"title":["Tumor Necrosis Factor-\u03b1 Is a Potent Endogenous Mutagen that Promotes Cellular Transformation"],"prefix":"10.1158","volume":"66","author":[{"given":"Bin","family":"Yan","sequence":"first","affiliation":[{"name":"1Radiation Oncology and Departments of"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Huili","family":"Wang","sequence":"additional","affiliation":[{"name":"2Medicine, Duke University Medical Center, Durham, North Carolina and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zahid N.","family":"Rabbani","sequence":"additional","affiliation":[{"name":"1Radiation Oncology and Departments of"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yulin","family":"Zhao","sequence":"additional","affiliation":[{"name":"1Radiation Oncology and Departments of"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wenrong","family":"Li","sequence":"additional","affiliation":[{"name":"3Department of Radiation Oncology, University of Colorado Health Sciences Center, Aurora, Colorado"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuqing","family":"Yuan","sequence":"additional","affiliation":[{"name":"1Radiation Oncology and Departments of"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fang","family":"Li","sequence":"additional","affiliation":[{"name":"3Department of Radiation Oncology, University of Colorado Health Sciences Center, Aurora, Colorado"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mark W.","family":"Dewhirst","sequence":"additional","affiliation":[{"name":"1Radiation Oncology and Departments of"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chuan-Yuan","family":"Li","sequence":"additional","affiliation":[{"name":"1Radiation Oncology and Departments of"},{"name":"3Department of Radiation Oncology, University of Colorado Health Sciences Center, Aurora, Colorado"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1086","published-online":{"date-parts":[[2006,12,18]]},"reference":[{"key":"2022061622105049500_B1","doi-asserted-by":"crossref","unstructured":"Moore RJ, Owens DM, Stamp G, et al. Mice deficient in tumor necrosis factor-\u03b1 are resistant to skin carcinogenesis. Nat Med\u20081999; 5: 828\u201331.","DOI":"10.1038\/10552"},{"key":"2022061622105049500_B2","unstructured":"Scott KA, Moore RJ, Arnott CH, et al. An anti-tumor necrosis factor-\u03b1 antibody inhibits the development of experimental skin tumors. Mol Cancer Ther\u20082003; 2: 445\u201351."},{"key":"2022061622105049500_B3","doi-asserted-by":"crossref","unstructured":"Coussens LM, Werb Z. Inflammation and cancer. Nature\u20082002; 420: 860\u20137.","DOI":"10.1038\/nature01322"},{"key":"2022061622105049500_B4","doi-asserted-by":"crossref","unstructured":"Duh EJ, Maury WJ, Folks TM, Fauci AS, Rabson AB. Tumor necrosis factor \u03b1 activates human immunodeficiency virus type 1 through induction of nuclear factor binding to the NF-\u03baB sites in the long terminal repeat. Proc Natl Acad Sci U S A\u20081989; 86: 5974\u20138.","DOI":"10.1073\/pnas.86.15.5974"},{"key":"2022061622105049500_B5","doi-asserted-by":"crossref","unstructured":"Natarajan K, Singh S, Burke TR, Jr., Grunberger D, Aggarwal BB. Caffeic acid phenethyl ester is a potent and specific inhibitor of activation of nuclear transcription factor NF-\u03baB. Proc Natl Acad Sci U S A\u20081996; 93: 9090\u20135.","DOI":"10.1073\/pnas.93.17.9090"},{"key":"2022061622105049500_B6","doi-asserted-by":"crossref","unstructured":"Balkwill F, Coussens LM. Cancer: an inflammatory link. Nature\u20082004; 431: 405\u20136.","DOI":"10.1038\/431405a"},{"key":"2022061622105049500_B7","doi-asserted-by":"crossref","unstructured":"Pikarsky E, Porat RM, Stein I, et al. NF-\u03baB functions as a tumour promoter in inflammation-associated cancer. Nature\u20082004; 431: 461\u20136.","DOI":"10.1038\/nature02924"},{"key":"2022061622105049500_B8","doi-asserted-by":"crossref","unstructured":"Luo JL, Maeda S, Hsu LC, Yagita H, Karin M. Inhibition of NF-\u03baB in cancer cells converts inflammation-induced tumor growth mediated by TNF\u03b1 to TRAIL-mediated tumor regression. Cancer Cell\u20082004; 6: 297\u2013305.","DOI":"10.1016\/j.ccr.2004.08.012"},{"key":"2022061622105049500_B9","doi-asserted-by":"crossref","unstructured":"Arnott CH, Scott KA, Moore RJ, et al. Tumour necrosis factor-\u03b1 mediates tumour promotion via a PKC\u03b1- and AP-1-dependent pathway. Oncogene\u20082002; 21: 4728\u201338.","DOI":"10.1038\/sj.onc.1205588"},{"key":"2022061622105049500_B10","doi-asserted-by":"crossref","unstructured":"Yan B, Wang H, Peng Y, et al. A unique role of the DNA fragmentation factor in maintaining genomic stability. Proc Natl Acad Sci U S A\u20082006; 103: 1504\u20139.","DOI":"10.1073\/pnas.0507779103"},{"key":"2022061622105049500_B11","doi-asserted-by":"crossref","unstructured":"Yan B, Wang H, Wang H, et al. Apoptotic DNA fragmentation factor maintains chromosome stability in a p53-independent manner. Oncogene\u20082006; 25: 5370\u20136.","DOI":"10.1038\/sj.onc.1209535"},{"key":"2022061622105049500_B12","doi-asserted-by":"crossref","unstructured":"Sanchez-Alcazar JA, Schneider E, Martinez MA, et al. Tumor necrosis factor-\u03b1 increases the steady-state reduction of cytochrome b of the mitochondrial respiratory chain in metabolically inhibited L929 cells. J Biol Chem\u20082000; 275: 13353\u201361.","DOI":"10.1074\/jbc.275.18.13353"},{"key":"2022061622105049500_B13","doi-asserted-by":"crossref","unstructured":"Schulze-Osthoff K, Bakker AC, Vanhaesebroeck B, Beyaert R, Jacob WA, Fiers W. Cytotoxic activity of tumor necrosis factor is mediated by early damage of mitochondrial functions. Evidence for the involvement of mitochondrial radical generation. J Biol Chem\u20081992; 267: 5317\u201323.","DOI":"10.1016\/S0021-9258(18)42768-8"},{"key":"2022061622105049500_B14","doi-asserted-by":"crossref","unstructured":"Li TK, Chen AY, Yu C, Mao Y, Wang H, Liu LF. Activation of topoisomerase II-mediated excision of chromosomal DNA loops during oxidative stress. Genes Dev\u20081999; 13: 1553\u201360.","DOI":"10.1101\/gad.13.12.1553"},{"key":"2022061622105049500_B15","doi-asserted-by":"crossref","unstructured":"Cadet J, Delatour T, Douki T, et al. Hydroxyl radicals and DNA base damage. Mutat Res\u20081999; 424: 9\u201321.","DOI":"10.1016\/S0027-5107(99)00004-4"},{"key":"2022061622105049500_B16","doi-asserted-by":"crossref","unstructured":"Guo Z, Boekhoudt GH, Boss JM. Role of the intronic enhancer in tumor necrosis factor-mediated induction of manganous superoxide dismutase. J Biol Chem\u20082003; 278: 23570\u20138.","DOI":"10.1074\/jbc.M303431200"},{"key":"2022061622105049500_B17","doi-asserted-by":"crossref","unstructured":"Lengauer C, Kinzler KW, Vogelstein B. Genetic instabilities in human cancers. Nature\u20081998; 396: 643\u20139.","DOI":"10.1038\/25292"},{"key":"2022061622105049500_B18","doi-asserted-by":"crossref","unstructured":"Um HD, Orenstein JM, Wahl SM. Fas mediates apoptosis in human monocytes by a reactive oxygen intermediate dependent pathway. J Immunol\u20081996; 156: 3469\u201377.","DOI":"10.4049\/jimmunol.156.9.3469"},{"key":"2022061622105049500_B19","doi-asserted-by":"crossref","unstructured":"Medan D, Wang L, Toledo D, et al. Regulation of Fas (CD95)-induced apoptotic and necrotic cell death by reactive oxygen species in macrophages. J Cell Physiol\u20082005; 203: 78\u201384.","DOI":"10.1002\/jcp.20201"}],"container-title":["Cancer Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/aacrjournals.org\/cancerres\/article-pdf\/66\/24\/11565\/2557380\/11565.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/aacrjournals.org\/cancerres\/article-pdf\/66\/24\/11565\/2557380\/11565.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,5,9]],"date-time":"2023-05-09T23:38:54Z","timestamp":1683675534000},"score":1,"resource":{"primary":{"URL":"https:\/\/aacrjournals.org\/cancerres\/article\/66\/24\/11565\/526566\/Tumor-Necrosis-Factor-Is-a-Potent-Endogenous"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2006,12,15]]},"references-count":19,"journal-issue":{"issue":"24","published-online":{"date-parts":[[2006,12,18]]},"published-print":{"date-parts":[[2006,12,15]]}},"URL":"https:\/\/doi.org\/10.1158\/0008-5472.can-06-2540","relation":{"has-preprint":[{"id-type":"doi","id":"10.1158\/0008-5472.c.6495425","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/0008-5472.c.6495425.v1","asserted-by":"object"}],"is-supplemented-by":[{"id-type":"doi","id":"10.1158\/0008-5472.22367099","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/0008-5472.22367102.v1","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/0008-5472.22367102","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/0008-5472.22367099.v1","asserted-by":"object"}],"has-review":[{"id-type":"doi","id":"10.3410\/f.1067098.520088","asserted-by":"object"}]},"ISSN":["0008-5472","1538-7445"],"issn-type":[{"value":"0008-5472","type":"print"},{"value":"1538-7445","type":"electronic"}],"subject":[],"published":{"date-parts":[[2006,12,15]]}}}